CEimpact Podcast
The CEimpact Podcast features two shows - GameChangers and Precept2Practice!
The GameChangers Clinical Conversations podcast, hosted by Josh Kinsey, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Pharmacist By Design™ subscribers can earn CE credit for each episode.
The Precept2Practice podcast, hosted by Kathy Schott, features information and resources for preceptors of students and residents. New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.
To support our shows, give us a follow and check back each week for our latest episodes.
CEimpact Podcast
Is Mirtazapine Appropriate for the Elderly?
A recent study calls into question the safety of mirtazapine in the elderly, an antidepressant often recommended in the elderly for treatment of senile cachexia due to the medication’s appetite stimulation properties. This episode reviews the SYMBAD trial with guest Sarah Grady, PharmD.
Guest:
Sarah Grady, PharmD
Drake University
Redeem your CPE or CME credit here!
Need a membership?
References and resources: Banerjee S, High J, Stirling S, et al. Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial. Lancet. 2021 Oct 23;398(10310):1487-1497. doi: 10.1016/S0140-6736(21)01210-1. PMID: 34688369; PMCID: PMC8546216.
Continuing Education Information:
Learning Objectives:
- Describe the results of the SYMBAD study and its implications in the care of geriatric patients
- Discuss the adverse effects found in the SYMBAD study
Dr. Sarah Grady reports no actual or potential conflicts of interest associated with this episode.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-401-H01-P
Initial release date: 12/20/21
Expiration date: 12/20/22
Additional CPE & CME details can be found here (www.ceimpact.com/podcast)